EUVIMEDEUVIMED entdecken
Crossref

Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring

Dustin D Linn iD, J Ross Renew

American Journal of Health-System Pharmacy · 07.11.2026

DOI: 10.1093/ajhp/zxag392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 07.11.2026. Verfasst von Dustin D Linn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Philips North America, Cambridge, MA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Philips North America, Cambridge, MA.
  • Department of Pharmacy, Parkview Health, Fort Wayne, IN USA.
  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Jacksonville, FL USA.

ORCID-Profile: Dustin D Linn

Zitieren

APA

Linn, D. D., & Renew, J. R. (2026). Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag392

Vancouver

Linn DD, Renew JR. Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxag392

BibTeX
@article{Linn2026,
  author = {Linn, Dustin D and Renew, J Ross},
  title = {Looking Beyond Drug Acquisition Costs: Generic Sugammadex and Quantitative Neuromuscular Monitoring},
  journal = {American Journal of Health-System Pharmacy},
  year = {2026},
  doi = {10.1093/ajhp/zxag392}
}
Kostenlos starten →